Search En menu en ClientConnect
Search
Results
Top 5 search results See all results Advanced search
Top searches
Most visited pages

    Signature(s)

    Amount
    € 26,305,727.8
    Countries
    Sector(s)
    Poland : € 26,305,727.8
    Education : € 13,152,863.9
    Health : € 13,152,863.9
    Signature date(s)
    28/06/2018 : € 13,152,863.9
    28/06/2018 : € 13,152,863.9
    Link to source

    Summary sheet

    Release date
    4 April 2018
    Status
    Reference
    Signed | 28/06/2018
    20170825
    Project name
    Promoter - financial intermediary
    POZNAN MEDICAL UNIVERSITY
    UNIWERSYTET MEDYCZNY IM KAROLA MARCINKOWSKIEGO W POZNANIU
    Proposed EIB finance (Approximate amount)
    Total cost (Approximate amount)
    PLN 115 million (EUR 27 million)
    PLN 234 million (EUR 55 million)
    Location
    Sector(s)
    Description
    Objectives

    The project involves the design, construction and equipment of a new state-of-the-art medical simulations centre at the Poznan Medical University. The project also includes the construction of the new building for the Faculty of Pharmacy and extension and rehabilitation of two university hospitals.

    The project aims to increase the educational, scientific and clinical potential of the Medical University in Poznan (UMP) by the design, construction and equipment of i) the Medical Simulations Centre, ii) the new seat of the Faculty of Pharmacy, iii) the extension and modernisation of the Heliodor Swiecicki University Hospital (emergency ward) and the Przemienienie Panskie Hospital (ophthalmic ward). Both hospitals are fully owned by the Medical University in Poznan and both are part of the Hospital Network. The project will help to modernise the curricula for undergraduate medical, pharmacy and health sciences students using top notch simulations' technology. The Medical Simulations Centre will also host, besides simulations units, departments of medical informatics, biostatistics and medicine of catastrophes. The new building of the faculty of pharmacy will host scientific laboratories of the Centre of Innovative Pharmaceutical Technologies as well as didactic premises. The construction of the new premises will add to intensification of scientific activities at UMP. The project is located in Poznan, Wielkopolskie voievodship, which is a convergence area.

    Environmental aspects
    Procurement

    The project comprises the construction of academic buildings and medical facilities. These types of projects are not specifically mentioned in the Environmental Impact Assessment (EIA) Directive 2014/52/EU amending Directive 2011/92/EU, though the project is covered by Annex II of the Directive in relation to urban development. The Bank's services will verify during the appraisal the screening decision of the Competent Authority. In line with Directive 2010/31/EU, public buildings will have to meet at least the relevant national targets on energy efficiency. The design energy performance of the hospital and any specific related targets to be met will be verified during the appraisal. It is expected that the project will bring wider benefits to the community as medical training and healthcare are elements of social cohesion and economic development.

    The Bank will require the promoter to ensure that contracts for the implementation of the project will be tendered in accordance with the relevant applicable EU procurement legislation, Directive 2014/24/EU, as well as Directive 89/665/EEC as interpreted by the Court of Justice of the European Union, with the publication of tender notices in the Official Journal of the European Union, as and where required.

    Link to source

    Disclaimer

    Before financing approval by the Board of Directors, and before loan signature, projects are under appraisal and negotiation. The information and data provided on this page are therefore indicative.
    They are provided for transparency purposes only and cannot be considered to represent official EIB policy (see also the Explanatory notes).

    Documents

    Environmental and Social Data Sheet (ESDS) - POZNAN MEDICAL UNIVERSITY
    Publication Date
    7 Apr 2020
    Document language
    Main Topic
    Lending
    Document Number
    80601064
    Document Focus
    Environmental Information
    Project Number
    20170825
    Sector(s)
    Regions
    Countries
    Publicly available
    Download now
    scoreboard - POZNAN MEDICAL UNIVERSITY
    Publication Date
    15 Jun 2018
    Document Language
    English
    Main Topic
    lending
    Document Number
    84259549
    Document Focus
    EFSI legal requirements
    Document Type
    Scoreboard
    Project Number
    20170825
    Last update
    15 Jun 2018
    Sector(s)
    Health, Education
    Countries
    Poland
    Publicly available
    Download now

    News & Stories

    General enquiries and comments

    The EIB is committed to open communication and encourages constructive stakeholder input regarding its activities.
    Enquiries and comments concerning the EIB’s involvement in a project or the financing facilities, activities, organisation and objectives of the EIB, can be sent to the EIB Infodesk.
    Alternatively, the EIB can be contacted through its external offices.
    Queries regarding details of a specific project, in particular when it is under appraisal by the EIB, should preferably be addressed directly to project promoters.

    Media enquiries

    Media-related enquiries can be addressed to the EIB Press Office. Please also visit our Media information section.

    Complaints mechanism

    Any complaint regarding alleged maladministration can be lodged via the EIB Complaints Mechanism. The European Ombudsman acts as an independent external accountability mechanism of the EIB.

    Zero tolerance against fraud and corruption

    The EIB has a zero tolerance policy on fraud or corruption. To report allegations of fraud and corruption relating to EIB-financed projects, please contact the Fraud and Investigation division. All complaints will be treated as strictly confidential and handled in line with the EIB investigation procedures and the Anti-Fraud Policy.

    Related publications